Prostate Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 45 years or older, up to 68 years of age
• People who have been diagnosed with prostate cancer confirmed by biopsy and have been treated with a robotic-assisted surgical removal of the prostate
• People whose surgery involved a technique that aimed to preserve the nerves around the prostate (on one or both sides)
• People who had normal bladder control (no leaking) before surgery
• People whose ability to get erections before surgery was in the moderate to mild-to-moderate range, based on a specific questionnaire score between 8 and 16 (confirm with trial site)

Who may not be able to join:

• People with severe intellectual difficulties that would prevent them from fully understanding what the study involves
• People whose prostate cancer is considered high risk, based on a specific protein level in the blood (PSA of 20 or above), a biopsy result showing a Gleason score of 8 or higher, or suspected spread to nearby tissue
• People where scans before surgery suggested the cancer had spread to bones or organs
• People who received hormone therapy to shrink the prostate cancer before surgery
• People who have had any previous treatment to the prostate, including certain bladder procedures or radiation therapy
• People who have previously had chemotherapy or surgery on the colon or rectum
• People who have had a previous pelvic injury that required surgery
• People with depression, dementia, schizophrenia, bipolar disorder, or other psychological or neurological conditions
• People with Peyronie's disease (a condition causing scar tissue in the penis)
• People with polyneuropathy (a condition affecting the nerves throughout the body)
• People with a high urinary symptom score (IPSS above 19) combined with a low quality-of-life score related to urinary symptoms (above 3) (confirm with trial site)
• People whose surgery involved complete or partial removal of the nerve bundles on both sides
• People who have a condition or take medication that makes them unable to safely take a common class of erectile dysfunction medicines called PDE5 inhibitors (confirm with trial site)
• People with a hormone or endocrine disorder, not including diabetes
• People in whom a specific small artery near the prostate (accessory pudendal artery) was identified and preserved during surgery (confirm with trial site)
• People whose surgery involved the use of certain electrical heat-based techniques (monopolar thermal application) in specific areas around the prostate and nerve bundles
• People who needed a return to surgery within 7 days after their prostate removal due to a serious complication
• People found to have a significant leak at the point where the bladder was reconnected, identified by a scan within 30 days after surgery

Important: Always verify eligibility with the trial site directly before applying.